Nancy Lynn MD Snyderman's Net Worth
$1.95 Million
Who is Nancy Lynn MD Snyderman?
Nancy Lynn MD Snyderman has an estimated net worth of $1.95 Million. This is based on reported shares across multiple companies, which include Future Health ESG Corp., Axonics, Inc., Alkermes plc., and Lyra Therapeutics, Inc..
SEC CIK
Nancy Lynn MD Snyderman's CIK is 0001675198
Past Insider Trading and Trends
2020 was Nancy Lynn MD Snyderman's most active year for acquiring shares with 7 total transactions. Nancy Lynn MD Snyderman's most active month to acquire stocks was the month of May. 2021 was Nancy Lynn MD Snyderman's most active year for disposing of shares, totalling 6 transactions. Nancy Lynn MD Snyderman's most active month to dispose stocks was the month of April. 2019 saw Nancy Lynn MD Snyderman paying a total of $74,240.00 for 45,650 shares, this is the most they've acquired in one year. In 2023 Nancy Lynn MD Snyderman cashed out on 7,387 shares for a total of $42,728.40, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Future Health ESG Corp. (FHLT) No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -13.04% | -3.38K |
—
|
—
| 22.51K |
Oct 24
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 14
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Axonics, Inc. (AXNX) Snapshot price: $67.8
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +17.71% | 3K |
—
|
—
| 19.94K |
Jun 26
| |||
Form 4
| +14.15% | 2.1K |
—
|
—
| 16.94K |
Aug 18
| |||
Form 4
| +17.97% | 2.26K |
—
|
—
| 14.84K |
Oct 22
| |||
Form 4
| +38.53% | 3.5K |
—
|
—
| 12.58K |
Aug 24
| |||
Form 4
| +29.76% | 2.08K |
—
|
—
| 9.08K |
Aug 22
| |||
Form 4
| +40.00% | 2K |
$37.12 | $74,240.00 | 7K |
Jun 27
| |||
Form 4
|
∞
| 5K |
—
|
—
| 5K |
Apr 8
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Alkermes plc. (ALKS) Snapshot price: $27.04
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +27.85% | 4.53K |
$29.88 | -$42,728.40 | 20.78K |
Jul 7
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 29
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 7
| |||
Form 4
| +73.56% | 6.89K |
$27.19 | -$18,897.05 | 16.26K |
Jun 14
| |||
Form 4
| +4.78% | 427 |
$23.43 | $10,004.61 | 9.37K |
Mar 4
| |||
Form 4
| +90.19% | 4.24K |
$22.11 | -$29,605.29 | 8.94K |
Dec 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 14
| |||
Form 4
|
∞
| 4.7K |
$21.92 | -$30,775.68 | 4.7K |
May 20
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 20
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 22
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 23
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 24
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 14
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Lyra Therapeutics, Inc. (LYRA) Snapshot price: $4.89
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 16
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 26
| |||
Form 4
|
∞
| 1.02K |
$9.72 | $9,963.00 | 1.02K |
Dec 16
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 27
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||